Table:
begin	end	state
1	28	cytoplasmic
29	49	transmembrane
50	54	non-cytoplasmic
55	79	transmembrane
80	90	cytoplasmic
91	111	transmembrane
112	116	non-cytoplasmic
117	139	transmembrane
140	162	cytoplasmic
163	183	transmembrane
184	194	non-cytoplasmic
195	214	transmembrane
215	245	cytoplasmic
246	270	transmembrane
271	283	non-cytoplasmic
284	305	transmembrane
306	313	cytoplasmic
314	335	transmembrane
336	343	non-cytoplasmic
344	368	transmembrane
369	386	cytoplasmic
387	408	transmembrane
409	413	non-cytoplasmic
414	434	transmembrane
435	467	cytoplasmic

Input:
>WP_012383191.1 NCBI__GCF_000019845.1:WP_012383191.1
MTTQRADSDVENGAGLKFLVFASSLGTMIEWYDFFLYGSLAVFFSELFYPKDNPVAALLI
SVATFATGFAVRPLGAVLFGHLGDRIGRKTTFLITLLLMGGATALIGILPTYASVGLLAP
VLLVVLRLIQGLALGGEYGGAATYVAEHAPDGRRGGWTSAIQTMASMGFFVSLAVVLSCR
FLLGDAIFASWGWRIPFLLSAVLVMLSLGARLRLAESPIFLQLKAEDRVSKSPVRESFAD
PRNRRLMLAVLFGVASGQAVTFYTANFYALYFLQSILKVDFLTSNLVMVLGVLIGMPLFV
LFGIWSDKIGRKPLIIAGMAAAVVLLVPIFMVMQSAVGPQGINIWLLAACVFVLVAIAAA
VYGPYAAYLVEVFPPQIRYTSLSIPYHIGNGIFGGFLPLIGLSLVAATGNPLAGLIYPIA
VCVINVIIGSLYLPETLHTPIDGRTSVEDLADESLPFAAALPPKSAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server